Suppr超能文献

组蛋白去乙酰化酶HDAC1在调节MyoD转录活性中的作用:对肌生成程序的抑制

A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program.

作者信息

Mal A, Sturniolo M, Schiltz R L, Ghosh M K, Harter M L

机构信息

Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

EMBO J. 2001 Apr 2;20(7):1739-53. doi: 10.1093/emboj/20.7.1739.

Abstract

The molecular mechanism(s) that are responsible for suppressing MyoD's transcriptional activities in undifferentiated skeletal muscle cells have not yet been determined. We now show that MyoD associates with a histone deacetylase-1 (HDAC1) in these cells and that this interaction is responsible for silencing MyoD-dependent transcription of endogenous p21 as well as muscle-specific genes. Specifically, we present evidence that HDAC1 can bind directly to MyoD and use an acetylated MyoD as a substrate in vitro, whereas a mutant version of HDAC1 (H141A) can not. Further more, this mutant also fails to repress MyoD-mediated transcription in vivo, and unlike wild-type HDAC1 it can not inhibit myogenic conversion, as judged by confocal microscopy. Finally, we show that an endogenous MyoD can be acetylated upon its conversion to a hypophosphorylated state and only when the cells have been induced to differentiate. These results provide for a model which postulates that MyoD may be co-dependent on HDAC1 and P/CAF for temporally controlling its transcriptional activity before and after the differentiation of muscle cells.

摘要

在未分化的骨骼肌细胞中,负责抑制MyoD转录活性的分子机制尚未确定。我们现在发现,在这些细胞中MyoD与组蛋白去乙酰化酶-1(HDAC1)相关联,并且这种相互作用导致内源性p21以及肌肉特异性基因的MyoD依赖性转录沉默。具体而言,我们提供的证据表明,HDAC1可直接与MyoD结合,并在体外将乙酰化的MyoD用作底物,而HDAC1的突变体(H141A)则不能。此外,该突变体在体内也无法抑制MyoD介导的转录,并且与野生型HDAC1不同,通过共聚焦显微镜判断,它不能抑制成肌转化。最后,我们表明内源性MyoD只有在细胞被诱导分化时,转化为低磷酸化状态后才能被乙酰化。这些结果提供了一个模型,该模型假设MyoD在肌肉细胞分化前后可能共同依赖HDAC1和P/CAF来暂时控制其转录活性。

相似文献

引用本文的文献

4
Emerging role of HDAC11 in skeletal muscle biology.组蛋白去乙酰化酶11在骨骼肌生物学中的新兴作用。
Front Cell Dev Biol. 2024 May 27;12:1368171. doi: 10.3389/fcell.2024.1368171. eCollection 2024.
6
The Current Landscape of Pharmacotherapies for Sarcopenia.肌少症药物治疗的现状。
Drugs Aging. 2024 Feb;41(2):83-112. doi: 10.1007/s40266-023-01093-7. Epub 2024 Feb 5.

本文引用的文献

6
Histone deacetylases: silencers for hire.组蛋白去乙酰化酶:受雇的沉默因子。
Trends Biochem Sci. 2000 Mar;25(3):121-6. doi: 10.1016/s0968-0004(00)01551-6.
7
Regulation of E2F1 activity by acetylation.通过乙酰化作用对E2F1活性的调控。
EMBO J. 2000 Feb 15;19(4):662-71. doi: 10.1093/emboj/19.4.662.
8
The many HATs of transcription coactivators.转录共激活因子的多种功能
Trends Biochem Sci. 2000 Jan;25(1):15-9. doi: 10.1016/s0968-0004(99)01516-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验